Investor's Business Daily on MSN

Catalyst Pharmaceuticals joins elite list of stocks with 95-plus composite rating

Catalyst Pharmaceuticals saw an improvement in its IBD SmartSelect Composite Rating Wednesday, from 94 to 96.
Zacks Investment Research on MSN

The Zacks rank explained: How to find strong buy medical stocks

It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck. But what's the best way ...